FDA-CMS collaboration aims to accelerate Medicare coverage determinations of certain medical devices
In both cases, the diagnostic tests report results back within 15 minutes
But anti-regulatory stance taken by Trump administration could serve as a potential obstacle in the effort
TruVerus is designed to perform a slew of clinical laboratory tests on as few as eight drops of blood
The two assays identify threats prior to prostate cancer being diagnosed and after it has undergone extensive treatment, respectively